Developing New Chemical Methods to Speed Up Cancer Drug Discovery
New Catalysts and Strategies for Selective C–H Functionalization and Cycloaddition Reactions
This research creates advanced chemical tools to help scientists find and develop new medicines for cancer more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11129775 on NIH RePORTER |
What this research studies
Finding new drugs for diseases like cancer can be a slow process, often limited by how quickly scientists can create and test new molecules. This project focuses on developing innovative chemical reactions and catalysts that make it easier and faster to build complex molecules needed for new medicines. By improving these fundamental chemical processes, the goal is to accelerate the discovery of effective small molecule therapeutics, especially for cancer treatment. We aim to overcome current challenges in chemical synthesis to provide powerful new platforms for drug development.
Who could benefit from this research
Good fit: This foundational chemistry research does not involve direct patient participation but aims to benefit future patients seeking new cancer treatments.
Not a fit: Patients not affected by cancer or those seeking immediate treatment options would not directly benefit from this early-stage chemical research.
Why it matters
Potential benefit: If successful, this work could significantly shorten the time it takes to discover and develop new, more effective drug treatments for cancer patients.
How similar studies have performed: While the field of chemical synthesis for drug discovery has seen considerable advancements, this project tackles specific barriers with novel catalytic approaches.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Hilinski, Michael Kenneth — University of Virginia
- Study coordinator: Hilinski, Michael Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.